Contact
searchSearch
HMP Global
Login

Oncology Innovations

Oncology Innovations, hosted by Gordon Kuntz, features candid discussions with innovators aiming to advance quality and value throughout the cancer care ecosystem.

Podcasts
Episode 6: Rapid Scientific Advancements in Value-Based Arrangements: Why Are Pathways Important?
06/29/2023
On episode 6 of Oncology Innovations, host Gordon Kuntz sits down with Aimee Ginsburg, PharmD, McKesson Value Pathways, to discuss the value of clinical pathways in a world of rapidly advancing scientific data, and how decision support tools...
On episode 6 of Oncology Innovations, host Gordon Kuntz sits down with Aimee Ginsburg, PharmD, McKesson Value Pathways, to discuss the value of clinical pathways in a world of rapidly advancing scientific data, and how decision support tools...
On episode 6 of Oncology...
06/29/2023
Journal of Clinical Pathways
Podcasts
Cancer Genomics and Genetic Testing in the Era of Precision Medicine: What is a Precision Model of Care?
12/05/2022
Gordon Kuntz and Dan Rhodes, PhD, discuss genomic testing and next-generation sequencing, the available technologies advancing the precision model of care, and exciting steps forward in the rapidly evolving oncology treatment landscape.
Gordon Kuntz and Dan Rhodes, PhD, discuss genomic testing and next-generation sequencing, the available technologies advancing the precision model of care, and exciting steps forward in the rapidly evolving oncology treatment landscape.
Gordon Kuntz and Dan Rhodes,...
12/05/2022
Journal of Clinical Pathways
Dan Rhodes, PhD
Podcasts
Episode 5: Cancer Genomics and Genetic Testing in the Era of Precision Medicine: What is a Precision Model of Care?
10/31/2022
Gordon Kuntz and Dan Rhodes, PhD, discuss genomic testing and next-generation sequencing, the available technologies advancing the precision model of care, and exciting steps forward in the rapidly evolving oncology treatment landscape.
Gordon Kuntz and Dan Rhodes, PhD, discuss genomic testing and next-generation sequencing, the available technologies advancing the precision model of care, and exciting steps forward in the rapidly evolving oncology treatment landscape.
Gordon Kuntz and Dan Rhodes,...
10/31/2022
Journal of Clinical Pathways
Ira Klein, MD, MBD
Oncology Innovations
Episode 4: Industry Standards Needed for Next-Generation Sequencing in Cancer Care
08/17/2022
Gordon Kuntz sits down with Ira Klein, MD, MBA, to discuss the need for industry standards in next-generation sequencing and comprehensive genomic profiling and how the lack of standards is impacting patients, providers, and payers.
Gordon Kuntz sits down with Ira Klein, MD, MBA, to discuss the need for industry standards in next-generation sequencing and comprehensive genomic profiling and how the lack of standards is impacting patients, providers, and payers.
Gordon Kuntz sits down with Ira...
08/17/2022
Journal of Clinical Pathways
Carole Tremonti, RN, MBA
Oncology Innovations
Episode 3: Artificial Intelligence-Driven Clinical Decision Support for Cancer Care: Where Are We Now?
08/01/2022
Gordon Kuntz sits down with Carole Tremonti, RN, MBA, of Project Ronin to discuss clinical decision support and artificial intelligence and their role in cancer care.
Gordon Kuntz sits down with Carole Tremonti, RN, MBA, of Project Ronin to discuss clinical decision support and artificial intelligence and their role in cancer care.
Gordon Kuntz sits down with...
08/01/2022
Journal of Clinical Pathways
Bo Gamble, Community Oncology Alliance
Oncology Innovations
Episode 2: ASCO-COA Oncology Medical Home Model Provides Standards for High-Quality, Evidence-Based Care
05/23/2022
Gordon Kuntz sits down with Bo Gamble of the Community Oncology Alliance to discuss the ASCO-COA Oncology Medical Home Model, which established core elements needed to deliver equitable, high-quality cancer care.
Gordon Kuntz sits down with Bo Gamble of the Community Oncology Alliance to discuss the ASCO-COA Oncology Medical Home Model, which established core elements needed to deliver equitable, high-quality cancer care.
Gordon Kuntz sits down with Bo...
05/23/2022
Journal of Clinical Pathways
Bryan Loy, MD, Humana
Oncology Innovations
Episode 1 Continued: The Value and Opportunity in Individualized Cancer Care: Part 2
12/01/2021

Gordon Kuntz; Bryan Loy, MD, MBA; and Tushar Pandey, MBA, discuss the reimbursement landscape and payer perspective on precision medicine and diagnostics and how stakeholders assess value.
Gordon Kuntz; Bryan Loy, MD, MBA; and Tushar Pandey, MBA, discuss the reimbursement landscape and payer perspective on precision medicine and diagnostics and how stakeholders assess value.
Gordon Kuntz; Bryan Loy, MD,...
12/01/2021
Journal of Clinical Pathways
Tushar Pandey
Oncology Innovations
Episode 1: The Value and Opportunity in Individualized Cancer Care: Part 1
11/17/2021
Gordon Kuntz; Bryan Loy, MD, MBA; and Tushar Pandey, MBA, discuss current approaches to personalized medicine, how precision medicine has evolved in recent years, challenges that remain, and considerations for the future.
Gordon Kuntz; Bryan Loy, MD, MBA; and Tushar Pandey, MBA, discuss current approaches to personalized medicine, how precision medicine has evolved in recent years, challenges that remain, and considerations for the future.
Gordon Kuntz; Bryan Loy, MD,...
11/17/2021
Journal of Clinical Pathways

Meet the Host:


Gordon Kuntz is a consultant with over 15 years of experience in oncology clinical pathways and the business of oncology. Since 2004, Gordon has worked with oncology clinical pathways for a variety of organizations, including US Oncology, ION Solutions/ AmerisourceBergen, Via Oncology/ Elsevier, and a large NCI Cancer Center with their own pathways. Gordon also serves as a member of the editorial advisory board for the Journal of Clinical Pathways.

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use